BOSTON and CAMBRIDGE, Mass., Sept. 14, 2026 /PRNewswire-PRWeb/ -- MadeAi, the AI-enabled evidence synthesis provider for life sciences, today announced that it has been named the winner of the 2026 Fierce AI Innovation Award for AI Innovation in Medical Affairs.
The Fierce AI Innovation Awards recognize innovative applications of artificial intelligence across the life sciences industry. MadeAi was recognized for its approach to accelerating literature review and evidence synthesis while maintaining the transparency, scientific rigor, and traceability required for regulated life sciences workflows.
"Medical Affairs teams are being asked to interpret an extraordinary and growing volume of scientific evidence, while expectations for speed, accuracy, and transparency continue to rise," said Gaugarin Oliver, Founder and CEO of MadeAi. "This award validates our belief that AI can fundamentally change how evidence is generated and used, not by removing scientific experts from the process, but by giving them a more powerful, traceable, and scalable way to work."
MadeAi combines generative AI, large language models, natural language processing, retrieval-augmented generation, agentic AI workflows, and human validation across the evidence synthesis process. The platform is designed to maintain source traceability and expert review while automating labor-intensive activities including protocol development, screening, data extraction, synthesis, summarization, and reporting.
By combining AI automation with human oversight, MadeAi helps Medical Affairs, HEOR, Market Access, and Real-World Evidence teams accelerate evidence workflows while supporting scientific confidence and audit readiness.
MadeAi supports pharmaceutical, biotechnology, medical device, and CRO organizations in transforming complex scientific information into trusted, evidence-based outputs.
The recognition follows Fierce's assessment of MadeAi as an AI-enabled, human-in-charge platform that helps automate labor-intensive literature review workflows while maintaining the scientific rigor required in life sciences.
About MadeAi
MadeAi™ is an AI-powered evidence synthesis and report generation platform purpose-built for life sciences. MadeAi helps organizations accelerate systematic literature reviews, GVD and JCA submissions, and evidence generation workflows across pharmaceutical, biotechnology, and medical device organizations.
From protocol to publication-ready deliverables, MadeAi combines artificial intelligence with human oversight to help research teams achieve faster turnaround times and scalable evidence generation.
Media Contact
Meghan Oates-Zalesky, MadeAi, 1 617 435 2470, [email protected], https://madeai.com/
SOURCE MadeAi
Share this article